Peripheral neuropathy associated with ipilimumab: A report of 2 cases Journal Article


Authors: Thaipisuttikul, I.; Chapman, P.; Avila, E. K.
Article Title: Peripheral neuropathy associated with ipilimumab: A report of 2 cases
Abstract: Ipilimumab, a monoclonal antibody targeting human cytotoxic T-lymphocyte-associated antigen 4, was approved by the FDA and European Medicines Agency for the treatment of metastatic melanoma. Immune-related adverse effects can occur with the use of this agent, but peripheral nervous system problems are rare. We report 2 cases of ipilimumab-induced polyneuropathy.
Keywords: ipilimumab; melanoma; sensorimotor polyneuropathy
Journal Title: Journal of Immunotherapy
Volume: 38
Issue: 2
ISSN: 1524-9557
Publisher: Lippincott Williams & Wilkins  
Date Published: 2015-02-01
Start Page: 77
End Page: 79
Language: English
DOI: 10.1097/cji.0000000000000070
PROVIDER: scopus
PUBMED: 25658617
PMCID: PMC5628623
DOI/URL:
Notes: Export Date: 2 March 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul Chapman
    326 Chapman
  2. Edward Kenneth Avila
    37 Avila